Clinical Trial Update: Multimodality- Adapted Dose Modification in Head and Neck Cancer Radiation Therapy  [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update for a multimodality-adapted dose modification approach in head and neck cancer undergoing radiation therapy (Phase 2/Phase 3) with unkno…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Head and Neck Cancer

Snippet

Sponsor: National Cancer Institute, Egypt | Conditions: Head and Neck Cancer | Phase 2, Phase 3 | Status: UNKNOWN